Finance
Markets
No recent trading data. The last price we hold for CNC is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

CNC

stock Healthcare Healthcare Plans
Centene Corporation
$59.55 -0.44 (-0.73%) Delayed · quoted 46d ago
Concerning 31% Steady

What the indicators say

Bullish 5 of 5 trend signals bullish
Momentum · RSI 14 Leaning bullish
65
0oversold 30overbought 70100

RSI 65 — firm momentum, not yet overbought.

EMA 21 $56.83
Above
Near-term trend is up
SMA 50 $47.29
Above
Medium-term trend is up
SMA 200 $40.16
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $55.15
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $58.23 High $60.50
Open
$59.55
-0.73%
Close
$59.55
-0.73%
52-week range where the price sits across its year
52w low $25.07 52w high $62.10
Current
$59.55
Prev close
$59.99
Volume 0.46× the 3-month average
0 avg 2× avg
Today
2.94M
3-mo avg
6.37M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2884 days ago
Next expected
Jul 28in 7 days

Recent earnings dates

  • Apr 28 84 days ago
  • Feb 6 165 days ago
  • Oct 29, 2025 265 days ago
  • Jul 25, 2025 361 days ago

Past earnings dates come from CNC’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Weak

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), CNC’s fundamentals read as weak overall.

P/E ratio No data
—

Earnings per share were negative, so a P/E cannot be formed; the company was unprofitable over the period.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Weak
-3.8%

A -3.8% margin is thin; little of each revenue dollar survives as profit.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Weak
-33.4%

A -33.4% return on equity is weak; owners' capital is barely being put to work.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Weak
-8.7%

A -8.7% return on assets is low; the asset base is generating little profit.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Weak
2.84

At 2.84, the company leans heavily on borrowing, which adds risk if results weaken.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.10

At 1.10, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Strong
+20.0%

Revenue grew 20.0% from the prior year: strong top-line expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-301.9%

Profit swung to a loss from a profitable prior year.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $118.0B$135.5B$140.1B$145.5B$174.6B
Net income $1.3B$1.2B$2.7B$3.3B-$6.7B
Diluted EPS $2.28$2.07$4.95$6.31$-13.53
Dividend / share —————
Total assets $78.4B$76.9B$84.6B$82.4B$76.7B
Total liabilities $51.4B$52.6B$58.7B$55.9B$56.7B
Shareholder equity $26.9B$24.2B$25.9B$26.4B$20.0B

Leadershipsynced from SEC 57d ago

  • London Sarah Chief Executive Officer · Director
  • Asher Andrew Lynn Chief Financial Officer
  • Smith Susan Raye Chief Operating Officer
  • Carson Michael A Group President, Medicare&Spec
  • Casso Katie Corporate Controller & CAO
  • Finke Daniel P Group President, Markets&Comm
  • Koster Christopher Secretary & General Counsel
  • Mcnally Tanya M Chief People Officer
  • Pienkos Theodore J Corporate Controller & CAO
  • Blume Jessica L. Director
  • Burdick Kenneth A Director
  • Coughlin Christopher J Director
  • Dallas H James Director
  • Eppinger Frederick H Director
  • Ford Monte E Director
  • Samuels Theodore R. Ii Director
  • Tanji Kenneth Director

Officers and board are drawn from CNC’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved